Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing. The solutions that the company offers include haematology, haemostasis, and urinalysis analyzers. It conducts research and development at its facilities in Japan, New Zealand, France, Germany and the US. The company operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia Pacific. Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.

Headquarters Japan

Address 1-5-1, Wakinohama Kaigandori, Chuo-Ku, Kobe-Shi, Hyogo, 651-0073


Telephone 81 78 2650500

No of Employees 8,445

Industry Medical Equipment

Ticker Symbol & Exchange 6869 (TYO)

Revenue (2022) $3.2B

EPS XXX

Market Cap* $12.1B

Net Profit Margin (2021) XXX -6.0%

   

* As of and is in US$

Explore premium data & analytics

120+

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

50+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

30+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

9

Clinical Trials

Determine Sysmex Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

5

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sysmex Corp’s relevant decision makers and contact details.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services Brands
Haematology Medical Services Sysmex
XN-series After-Sales Services
XT-series Systemisation
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Acquisitions/Mergers/Takeovers In May, the company acquired Astrego Diagnostics AB and changed its name to Sysmex Astrego AB.
2022 Contracts/Agreements In February, the company formed a capital and business tie-up with KAINOS Laboratories, Inc. to develop and produce diagnostic reagents in the immunochemistry field.
2022 Corporate Changes/Expansions In February, the company announced the establishment of a new subsidiary, Sysmex LLC in Saudi Arabia.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Sysmex Corp F. Hoffmann-La Roche Ltd Siemens Healthineers AG Becton Dickinson and Co bioMerieux SA
Headquarters Japan Switzerland Germany United States of America France
City Kobe-Shi Basel Erlangen Franklin Lakes Craponne
State/Province Hyogo - - New Jersey -
No. of Employees 8,445 100,920 66,800 75,000 13,076
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more

Key Financial Charts

Operating Margin
Operating Margin
EPS (Earnings per Share)
EPS (Earnings per Share)
Debt to Equity Ratio
Debt to Equity Ratio
Return on Assets
Return on Assets
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Hisashi Ietsugu Chairman; Chief Executive Officer Executive Board 2013 -
Kaoru Asano Senior Managing Director; Senior Executive Officer; Director; Chief Technology Officer Executive Board 2017 -
Iwane Matsui Senior Executive Officer; Managing Director; Director Executive Board - -
Hiroshi Kanda Managing Director; Director; Senior Executive Officer Executive Board - -
Kenji Tachibana Senior Managing Director; Director; Senior Executive Officer Executive Board 2017 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer